Prognostic Value of Receptor Change After Neoadjuvant Chemotherapy in Breast Cancer Patients.
Özlem ÖzdemirYasar YildizDemet Kocatepe ÇavdarCengiz Yılmazİsabel Raika DurusoyPublished in: European journal of breast health (2022)
These results suggest there is a need for reassessment of HR and HER-2 status in surgical samples from patients following NAC, and that NAC-induced changes in the HR state may be used as a prognostic factor.